Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registryMartin Metzenmacher, Wilfried Eberhardt, Harald Schäfer et al.|European Respiratory Journal|2022Cited by 17
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)Frank Griesinger, Dimitri Flieger, Wilfried Eberhardt et al.|JTO Clinical and Research Reports|2023Cited by 4